Diabetic Ketoacidosis(DKA) Flashcards
in what circumstances does DKA usually occur
absolute or relative insulin deficiency, accompanied by an increase in the counter-regulatory hormones(eg glucagon, adrenal, cortisol, GH)
in what types of diabetes can DKA occur, and what type does it most often occur in
type 1 or type 2, but mostly occurs in type 1
describe the pathophysiology of DKA
when insulin deficiency, glucose can’t enter the cells so instead of glucose other metabolites are used, one of which is lipids which metabolised forms FFAs and build up leads to ketogenesis/acidosis
what measurements are used in the biochemical diagnosis of DKA (3)
ketonaemia >3mmol/l, or ketonuria >2 on urine stick
BG >11mmol/l, or known diabetic
Bicarbonate <15mmol/l, or venous pH<7.3
what are some of the causes of death in people with DKA
hypokalaemia, aspiration pneumonia, ARDS
cerebral oedema in children
(only 2-5% mortality for DKA)
what are the precipitants of DKA due to insulin deficiency
newly diagnosed patients, or non-adherence/poor self-management is commonest cause
what are the precipitants of DKA due to increased insulin demand
infections(eg pneumonia), inflammation(eg pancreatitis), intoxication(eg alcohol), infarction(eg acute MI), iatrogenic(eg steroids)
what are the typical osmotic related signs and symptoms of DKA
thirst, polyuria, dehydration
what are the typical ketone body related signs and symptoms of DKA
flushed, vomiting, abdo pain/tenderness, breathless, palpitations/chest pain
(note not all patients can smell ketones on breath)
what are some typical associated conditions with DKA
underlying sepsis, gastroenteritis
describe the monitoring of potassium in DKA
often above 5.5mmol/l at start, but soon as insulin given can drop and cause hypokalaemia if not monitored and replenished
describe the levels of sodium, creatinine and amylase in DKA
sodium = often low or low normal creatinine = often raised amylase = often raised
what are the management principles for DKA
replace losses, address risks, IV fluid resuscitation, monitoring
what losses need to be replaced in DKA treatment
fluid(initially with 0.9% sodium, then switch to dextrose when glucose drops to 15)
insulin, potassium, phosphate
what risks need to be addressed when treating DKA
is naso-gastric tube needed?, monitor K+, prescribe prophylactic LMWH, source sepsis(CXR, blood culture etc.)
describe the IV Fluid resuscitation treatment for DKA
1000ml NaCl 0.9% in first hour
2000ml NaCl by 2 hours
3000ml NaCl by 4 hours
describe the biochemistry monitoring during DKA treatment
blood for U&Es and bicarbonate level at start, hour 2 and hour 4
IV K+ replacement
what insulin should be given in DKA treatment
‘usual’ subcutaneous insulin given daily along with IV insulin
describe the urine ketone monitoring of DKA patients
urine ketone testing - measure acetoacetate, indicates last 2-4hr ketone levels
(note ketonuria continues after clinical improvement due to mobilisation of ketones from fat tissue)
describe the blood ketone monitoring of DKA patients
blood ketone testing - optium metre, measure beta-hydroxybutyrate, metre range 0-8mmol/l, normal <0.6mmol/l
what is beta-hydroxybutyrate
one of the main ketones that is measured in DKA
what can be done to prevent recurrence of DKA
if new patient/poor management give education about diabetes management and ‘sick day’ rules, can give ketone monitors, arrange follow up consultations and inform local GP